1
|
Koom WS, Ahn SD, Song SY, Lee CG, Moon SH,
Chie EK, Jang HS, Oh YT, Lee HS and Keum KC: Nutritional status of
patients treated with radiotherapy as determined by subjective
global assessment. Radiat Oncol J. 30:132–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Righini CA, Timi N, Junet P, Bertolo A,
Reyt E and Atallah I: Assessment of nutritional status at the time
of diagnosis in patients treated for head and neck cancer. Eur Ann
Otorhinolaryngol Head Neck Dis. 130:8–14. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Martín-Villares C, San Román-Carbajo J,
Fernández-Pello ME, Tapia Risueño M and Domínguez Calvo J:
Nutritional status in head and neck cancer patients: the impact on
the prognosis. Nutr Hosp. 18:91–94. 2003.(In Spanish).
|
4
|
Borek C: Antioxidants and radiation
therapy. J Nutr. 134:3207S–3209S. 2004.PubMed/NCBI
|
5
|
Michalowski AS: On radiation damage to
normal tissues and its treatment. II Anti-inflammatory drugs. Acta
Oncol. 33:139–157. 1994. View Article : Google Scholar : PubMed/NCBI
|
6
|
Peters LJ: Radiation therapy tolerance
limits. For one or for all? - Janeway Lecture. Cancer.
77:2379–2385. 1996. View Article : Google Scholar : PubMed/NCBI
|
7
|
Fridlyand LE and Philipson LH: Oxidative
reactive species in cell injury: mechanisms in diabetes mellitus
and therapeutic approaches. Ann NY Acad Sci. 1066:136–151. 2005.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Baynes JW: Role of oxidative stress in
development of complications in diabetes. Diabetes. 40:405–412.
1991. View Article : Google Scholar : PubMed/NCBI
|
9
|
Scully C, Epstein J and Sonis S: Oral
mucositis: a challenging complication of radiotherapy,
chemotherapy, and radiochemotherapy: part 1, pathogenesis and
prophylaxis of mucositis. Head Neck. 25:1057–1070. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Denis F, Garaud P, Bardet E, Alfonsi M,
Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J and Calais G:
Final results of the 94-01 French Head and Neck Oncology and
Radiotherapy Group randomized trial comparing radiotherapy alone
with concomitant radiochemotherapy in advanced-stage oropharynx
carcinoma. J Clin Oncol. 22:69–76. 2004. View Article : Google Scholar
|
11
|
Fisher J, Scott C, Scarantino CW, Leveque
FG, White RL, Rotman M, Hodson DI, Meredith RF, Foote R, Bachman DG
and Lee N: Phase III quality-of-life study results: impact on
patients’ quality of life to reducing xerostomia after radiotherapy
for head-and-neck cancer - RTOG 97-09. Int J Radiat Oncol Biol
Phys. 56:832–836. 2003.
|
12
|
Chencharick JD and Mossman KL: Nutritional
consequences of the radiotherapy of head and neck cancer. Cancer.
51:811–815. 1983. View Article : Google Scholar : PubMed/NCBI
|
13
|
Calviello G, Serini S, Piccioni E and
Pessina G: Antineoplastic effects of n-3 polyunsaturated fatty
acids in combination with drugs and radiotherapy: preventive and
therapeutic strategies. Nutr Cancer. 61:287–301. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ruxton CH, Reed SC, Simpson MJ and
Millington KJ: The health benefits of n-3 polyunsaturated fatty
acids: a review of the evidence. J Hum Nutr Diet. 20:275–285. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Fearon KC, Von Meyenfeldt MF, Moses AG,
Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J,
Barber MD, Aaronson NK, Voss AC and Tisdale MJ: Effect of a protein
and energy dense N-3 fatty acid enriched oral supplement on loss of
weight and lean tissue in cancer cachexia: a randomised double
blind trial. Gut. 52:1479–1486. 2003. View Article : Google Scholar : PubMed/NCBI
|
16
|
Moses AW, Slater C, Preston T, Barber MD
and Fearon KC: Reduced total energy expenditure and physical
activity in cachectic patients with pancreatic cancer can be
modulated by an energy and protein dense oral supplement enriched
with n-3 fatty acids. Br J Cancer. 90:996–1002. 2004. View Article : Google Scholar
|
17
|
Bruera E, Strasser F, Palmer JL, Willey J,
Calder K, Amyotte G and Baracos V: Effect of fish oil on appetite
and other symptoms in patients with advanced cancer and
anorexia/cachexia: a double-blind, placebo-controlled study. J Clin
Oncol. 21:129–134. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Arends J, Bodoky G, Bozzetti F, Fearon K,
Muscaritoli M, Selga G and van Bokhorst-de van der Schueren MA;
DGEM (German Society for Nutritional Medicine). Zürcher G, Fietkau
R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ and Zander A;
ESPEN (European Society for Parenteral and Enteral Nutrition).
ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin
Nutr. 25:245–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Jones D: ICRU Report 50 - Prescribing,
recording and reporting photon beam therapy. Med Phys. 21:8331999.
View Article : Google Scholar
|
20
|
Cox JD, Stetz J and Pajak TF: Toxicity
Criteria of the Radiation Therapy Oncology Group (RTOG) and the
European Organization for Research and Treatment of Cancer (EORTC).
Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ali EM and Abdelraheem AG: Concurrent
radiotherapy and chemotherapy for locally advanced squamous cell
carcinoma of the head and neck. Head Neck Oncol. 3:482011.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Somani N, Goyal S, Pasricha R, Khuteta N,
Agarwal P, Garg AK and Singhal H: Sequential therapy (triple
drug-based induction chemotherapy followed by concurrent
chemoradiotherapy) in locally advanced inoperable head and neck
cancer patients - Single institute experience. Indian J Med
Paediatr Oncol. 32:86–91. 2011. View Article : Google Scholar
|
23
|
Kubrak C, Olson K, Jha N, Scrimger R,
Parliament M, McCargar L, Koski S and Baracos VE: Clinical
determinants of weight loss in patients receiving radiation and
chemoirradiation for head and neck cancer: a prospective
longitudinal view. Head Neck. 35:695–703. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chen CC, Chen WC, Lu CH, Wang WH, Lin PY,
Lee KD and Chen MF: Significance of interleukin-6 signaling in the
resistance of pharyngeal cancer to irradiation and the epidermal
growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys.
76:1214–1224. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Mahdavi R, Faramarzi E, Mohammad-Zadeh M,
Ghaeammaghami J and Jabbari MV: Consequences of radiotherapy on
nutritional status, dietary intake, serum zinc and copper levels in
patients with gastrointestinal tract and head and neck cancer.
Saudi Med J. 28:435–440. 2007.PubMed/NCBI
|
26
|
Reddy VS, Dakshinamurty KV, Sherke RL and
Neela Prasadd T: N-3 Polyunsaturated fatty acids in the prevention
of progression of chronic renal disease. Indian J Nephrol. 12:6–9.
2002.
|
27
|
Sarsilmaz M, Songur A, Ozyurt H, Kuş I,
Ozen OA, Ozyurt B, Söğüt S and Akyol O: Potential role of dietary
ω-3 essential fatty acids on some oxidant/antioxidant parameters in
rats’ corpus striatum. Prostaglandins Leukot Essent Fatty Acids.
69:253–259. 2003.
|
28
|
Hauenschild A, Bretzel RG,
Schnell-Kretschmer H, Kloer HU, Hardt PD and Ewald N: Successful
treatment of severe hypertriglyceridemia with a formula diet rich
in n-3 fatty acids and medium-chain triglycerides. Ann Nutr Metab.
56:170–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Dhankhar R, Dahiya K, Sharma TK, Ghalaut
VS, Atri R and Kaushal V: Diagnostic significance of adenosine
deaminase, uric acid and C-reactive protein levels in patients of
head and neck carcinoma. Clin Lab. 57:795–798. 2011.PubMed/NCBI
|
30
|
Bechoua S, Dubois M, Dominguez Z,
Goncalves A, Némoz G, Lagarde M and Prigent AF: Protective effect
of docosahexaenoic acid against hydrogen peroxide-induced oxidative
stress in human lymphocytes. Biochem Pharmacol. 57:1021–1030. 1999.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Machon C, Thezenas S, Dupuy AM, Assenat E,
Michel F, Mas E, Senesse P and Cristol JP: Immunonutrition before
and during radiochemotherapy: improvement of inflammatory
parameters in head and neck cancer patients. Support Care Cancer.
20:3129–3135. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Chen HH, Chen IH, Liao CT, Wei FC, Lee LY
and Huang SF: Preoperative circulating C-reactive protein levels
predict pathological aggressiveness in oral squamous cell
carcinoma: a retrospective clinical study. Clin Otolaryngol.
36:147–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zeng YC, Xue M, Chi F, Xu ZG, Fan GL, Wu
R, Fan YC, Zhong WZ, Wang SL, Zhang XY, Wu LN, Chen XD, Jin XY,
Duan QY, Xu R, Chen W, Qian HC and Xiao YP: C-reactive protein
level predicts prognosis in patients with locoregionally advanced
laryngeal carcinoma treated with chemoradiotherapy. Tumour Biol.
33:891–895. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Peter F, Wittekindt C, Finkensieper M,
Kiehntopf M and Guntinas-Lichius O: Prognostic impact of
pretherapeutic laboratory values in head and neck cancer patients.
J Cancer Res Clin Oncol. 139:171–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Helzlsouer KJ, Erlinger TP and Platz EA:
C-reactive protein levels and subsequent cancer outcomes: results
from a prospective cohort study. Eur J Cancer. 42:704–707. 2006.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Mojtahedi Z, Khademi B, Hashemi SB, Abtahi
SM, Ghasemi MA, Fattahi MJ and Ghaderi A: Serum interleukin-6
concentration, but not interleukin-18, is associated with head and
neck squamous cell carcinoma progression. Pathol Oncol Res.
17:7–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Yadav A, Kumar B, Datta J, Teknos TN and
Kumar P: IL-6 promotes head and neck tumor metastasis by inducing
epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling
pathway. Mol Cancer Res. 9:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
38
|
Brailo V, Vucicevic-Boras V, Lukac J,
Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A and Balija M:
Salivary and serum interleukin 1 beta, interleukin 6 and tumor
necrosis factor alpha in patients with leukoplakia and oral cancer.
Med Oral Patol Oral Cir Bucal. 17:e10–e15. 2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
De Schutter H, Landuyt W, Verbeken E,
Goethals L, Hermans R and Nuyts S: The prognostic value of the
hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in
head and neck squamous cell carcinoma treated by radiotherapy
chemotherapy. BMC Cancer. 5:422005.PubMed/NCBI
|
40
|
Nibali L, Fedele S, D’Aiuto F and Donos N:
Interleukin-6 in oral diseases: a review. Oral Dis. 18:236–243.
2012. View Article : Google Scholar : PubMed/NCBI
|
41
|
Mohammed FF, Poon I, Zhang L, Elliott L,
Hodson ID, Sagar SM and Wright J: Acute-phase response reactants as
objective biomarkers of radiation-induced mucositis in head and
neck cancer. Head Neck. 34:985–993. 2012. View Article : Google Scholar : PubMed/NCBI
|
42
|
Salzman R, Pácal L, Kaňková K, Tomandl J,
Horáková Z, Tóthová E and Kostřica R: High perioperative level of
oxidative stress as a prognostic tool for identifying patients with
a high risk of recurrence of head and neck squamous cell carcinoma.
Int J Clin Oncol. 15:565–570. 2010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Ziech D, Franco R, Pappa A and
Panayiotidis MI: Reactive oxygen species (ROS)-induced genetic and
epigenetic alterations in human carcinogenesis. Mutat Res.
711:167–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
44
|
Sharma PK, Dwarakanath BS and Varshney R:
Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide
involves activation of redox sensitive ASK1-JNK/p38MAPK signaling
in head and neck cancer cells. Free Radic Biol Med. 53:1500–1513.
2012. View Article : Google Scholar : PubMed/NCBI
|
45
|
Simone NL, Soule BP, Ly D, Saleh AD,
Savage JE, Degraff W, Cook J, Harris CC, Gius D and Mitchell JB:
Ionizing radiation-induced oxidative stress alters miRNA
expression. PloS One. 4:e63772009. View Article : Google Scholar : PubMed/NCBI
|
46
|
Park KS, Lim JW and Kim H: Inhibitory
mechanism of n-3 fatty acids in pancreatic inflammation and
apoptosis. Ann NY Acad Sci. 1171:421–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
47
|
Fu TY, Hou YY, Chu ST, Liu CF, Huang CH,
Chen HC, Hsiao M, Lu PJ, Wang JS and Ger LP: Manganese superoxide
dismutase and glutathione peroxidase as prognostic markers in
patients with buccal mucosal squamous cell carcinomas. Head Neck.
33:1606–1615. 2011. View Article : Google Scholar : PubMed/NCBI
|
48
|
Liu Z, Li S, Cai Y, Wang A, He Q, Zheng C,
Zhao T, Ding X and Zhou X: Manganese superoxide dismutase induces
migration and invasion of tongue squamous cell carcinoma via
H2O2-dependent Snail signaling. Free Radic
Biol Med. 53:44–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
49
|
Chen B, Rao X, House MG, Nephew KP, Cullen
KJ and Guo Z: GPx3 promoter hypermethylation is a frequent event in
human cancer and is associated with tumorigenesis and chemotherapy
response. Cancer Lett. 309:37–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
50
|
Korde SD, Basak A, Chaudhary M, Goyal M
and Vagga A: Enhanced nitrosative and oxidative stress with
decreased total antioxidant capacity in patients with oral
precancer and oral squamous cell carcinoma. Oncology. 80:382–389.
2011. View Article : Google Scholar : PubMed/NCBI
|
51
|
Dahiya K, Dhankhar R, Madaan H, Singh V
and Arora K: Nitric oxide and antioxidant status in head and neck
carcinoma before and after radiotherapy. Ann Clin Lab Sci.
42:94–97. 2012.PubMed/NCBI
|
52
|
Mazière C, Conte MA, Degonville J, Ali D
and Mazière JC: Cellular enrichment with polyunsaturated fatty
acids induces an oxidative stress and activates the transcription
factors AP1 and NFkappaB. Biochem Biophys Res Commun. 265:116–122.
1999.PubMed/NCBI
|
53
|
Hafer K, Iwamoto KS and Schiestl RH:
Refinement of the dichlorofluorescein assay for flow cytometric
measurement of reactive oxygen species in irradiated and bystander
cell populations. Radiat Res. 169:460–468. 2008. View Article : Google Scholar : PubMed/NCBI
|